type
iii
interferon
ifnl
also
known
discov
antivir
function
expect
analog
type
ifn
ifna
ifnb
via
induct
ifnstimul
gene
isg
although
ifnl
stimul
express
antivir
isg
preferenti
cell
epitheli
origin
recent
studi
defin
addit
antivir
mechan
cell
type
tissu
viral
infect
model
use
mice
lack
ifnl
signal
snp
associ
human
diseas
expand
understand
contribut
ifnl
antivir
respons
anatom
barrier
immun
respons
beyond
barrier
review
highlight
recent
insight
ifnl
function
includ
abil
restrict
viru
spread
brain
clear
chronic
viral
infect
gastrointestin
tract
also
discuss
ifnl
modul
innat
adapt
immun
autoimmun
tumor
progress
possibl
therapeut
applic
human
diseas
interferonl
ifnl
also
term
type
iii
ifn
belong
cytokin
famili
share
function
similar
famili
type
ifn
ifna
andor
ifnb
hereaft
ifnab
ifnl
ifnab
multigen
famili
compos
close
relat
cytokin
specif
heterodimer
receptor
ifnlr
ifnl
ifnar
ifnab
human
gene
encod
four
ifnl
protein
well
ifnab
protein
ifna
subtyp
ifnb
ifnu
ifnk
contrast
ifnab
famili
describ
almost
year
ago
isaac
lindenmann
ifnl
famili
discov
recent
human
identifi
kotenko
et
al
sheppard
et
al
time
consid
pseudogen
becam
clear
mani
human
function
common
snp
result
frameshift
mutat
ablat
product
popul
ham
et
al
prokuninaolsson
et
al
gene
encod
type
ifn
characterist
lack
intron
except
ifnk
synten
singl
locu
human
chromosom
mous
chromosom
gene
encod
ifnl
locat
human
chromosom
mous
chromosom
share
gene
structur
characterist
cytokin
famili
member
sabat
discuss
herein
recent
review
donnelli
kotenko
durbin
et
al
egli
et
al
griffith
et
al
hoffmann
et
al
koch
finotto
kotenko
obrien
et
al
odendal
kagan
sever
aspect
ifnl
biolog
differ
ifnab
biolog
first
effect
ifnl
evid
epitheli
cell
suggest
contribut
special
immun
mechan
protect
epitheli
surfac
undergo
constant
exposur
commens
pathogen
microb
durbin
et
al
iv
et
al
second
focus
natur
signal
effect
ifnl
might
share
therapeut
benefit
yet
avoid
mani
side
effect
limit
clinic
use
ifnab
donnelli
et
al
markowitz
pagliaccetti
robek
pestka
third
genomewid
associ
studi
gwass
reveal
multipl
ifnl
polymorph
link
clearanc
hepat
c
viru
hcv
infect
possibl
improv
outcom
viral
infect
includ
hepat
b
viru
hbv
human
cytomegaloviru
hcmv
herp
simplex
viru
egli
et
al
galmozzi
et
al
griffith
et
al
lampertico
et
al
manuel
et
al
review
discuss
new
insight
antivir
function
ifnl
especi
distinguish
ifnab
also
describ
ifnl
modul
adapt
immun
autoimmun
tumor
progress
well
possibl
therapeut
applic
human
diseas
highlight
special
role
ifnl
provid
antivir
activ
anatom
barrier
includ
epitheli
surfac
bloodbrain
barrier
bbb
epitheli
surfac
experi
constant
microbi
exposur
ifnl
might
provid
target
antivir
protect
key
barrier
site
without
activ
system
proinflammatori
immun
respons
stimuli
induc
express
ifnlencod
gene
includ
rang
virus
similar
induc
express
gene
encod
ifnab
ank
et
al
ank
et
al
durbin
et
al
kotenko
et
al
sheppard
et
al
nonetheless
differ
transcript
factor
requir
ifnab
ifnl
given
differ
review
previous
durbin
et
al
highlight
recent
advanc
understand
transcript
regul
ifnlencod
gene
ifn
express
occur
host
detect
pathogenassoci
molecular
pattern
specif
patternrecognit
receptor
prr
swiecki
colonna
figur
although
prr
respons
induc
express
ifnl
overlap
trigger
ifnab
express
cytosol
dna
sensor
activ
express
ifnl
ifnab
zhang
et
al
transcript
factor
activ
downstream
prr
signal
includ
interferon
regulatori
factor
irf
nfkb
suit
prr
transcript
factor
express
cell
contribut
specif
capabl
magnitud
ifn
respons
follow
infect
hillyer
et
al
exampl
ifnb
induc
earli
activ
prr
promot
bound
constitut
express
wherea
ifna
subtyp
induc
preferenti
encod
ifnstimul
gene
isg
nin
et
al
initi
character
promot
region
upstream
identifi
bind
element
nfkb
combin
activ
irf
nfkb
requir
maxim
gene
induct
onoguchi
et
al
osterlund
et
al
thomson
et
al
subsequ
analysi
respons
agonist
show
ifnl
induct
exhibit
greater
depend
nfkb
ifnab
induct
find
suggest
despit
similar
promot
featur
discrimin
ifnl
ifnab
induct
addit
factor
distinguish
regul
ifnl
ifnab
induct
compon
mediat
complex
interact
enhanc
transcript
promot
ifnb
promot
result
increas
ifnl
product
inhibit
replic
griffith
et
al
bioinformat
biochem
analysi
region
upstream
human
identifi
bind
site
transcript
factor
experi
use
chromatin
immunoprecipit
gene
silenc
establish
bind
promot
repress
transcript
airway
intestin
epitheli
cell
line
siegel
et
al
swider
et
al
activ
specif
regul
ifnb
express
function
repressor
displac
bind
siegel
et
al
requir
ifnb
transcript
odendal
et
al
although
ifnl
ifnb
induc
downstream
prr
sens
activ
mitochondri
antivir
signal
protein
mav
ifnl
product
favor
activ
mav
local
peroxisom
wherea
ifnb
product
domin
mav
local
mitochondria
odendal
et
al
rel
abund
peroxisom
epitheli
cell
suggest
mechan
preferenti
product
ifnl
instead
ifnb
respons
viral
infect
epitheli
surfac
hepatocyt
hbv
infect
stimul
product
ifnl
ifnab
ifnl
induct
depend
recognit
rigi
signal
mav
sato
et
al
similarli
hcv
infect
preferenti
induc
ifnl
ifnab
marukian
et
al
park
et
al
thoma
et
al
suggest
liverspecif
factor
might
promot
ifnl
product
respons
unrel
hepatotrop
virus
although
epitheli
cell
produc
ifnl
myeloidlineag
cell
major
sourc
respons
doublestrand
rna
poli
c
viral
infect
lauterbach
et
al
small
intestin
epitheli
cell
immun
cell
respond
poli
c
stimul
suggest
multipl
cell
type
produc
ifnl
cooper
although
gut
immun
cell
treat
poli
c
produc
ifnb
ifnl
product
induc
viral
infect
sens
pattern
recognit
receptor
prr
includ
member
rigilik
receptor
rlr
tolllik
receptor
tlr
famili
well
dna
sensor
wherea
ifnl
induc
via
mani
signal
pathway
induc
ifnab
peroxisomeloc
mav
preferenti
induc
ifnl
ifnl
signal
heterodimer
receptor
ifnlr
compos
subunit
canon
signal
ifnlr
activ
kinas
phosphoryl
howev
ifnlr
signal
also
activ
downstream
signal
pathway
depict
jakstat
signal
induc
express
ifnstimul
gene
isg
product
effector
molecul
inhibit
viral
infect
among
isg
induc
ifnl
encod
transcript
factor
respect
amplifi
ifn
product
gut
epitheli
cell
exclus
gener
iv
et
al
perhap
reflect
peroxisom
content
odendal
et
al
also
differ
ifn
induct
profil
within
myeloid
cell
compart
stimul
prr
agonist
wherea
plasmacytoid
dendrit
cell
dc
produc
nearli
ifn
includ
ifnl
monocyt
myeloid
dc
select
express
ifnb
hillyer
et
al
similarli
dc
major
ifnlproduc
myeloid
cell
type
respons
poli
c
mice
lauterbach
et
al
proxim
signal
event
downstream
transcript
respons
similar
ifnab
ifnl
even
though
cytokin
receptor
structur
genet
distinct
structur
ifnl
resembl
member
famili
although
primari
amino
acid
sequenc
similar
ifnab
mikni
et
al
wherea
type
ifn
signal
share
heterodimer
receptor
ifnar
type
iii
ifn
bind
ifnlr
uniqu
heterodimer
receptor
ifnlr
consist
one
subunit
share
famili
cytokin
second
specif
ifnl
also
call
despit
structur
similar
ifnl
famili
cytokin
ie
crystal
structur
bound
reveal
distinct
receptorbind
interact
includ
stoichiometri
compar
mikni
et
al
impact
share
chain
interact
ifnl
famili
cytokin
remain
unclear
ifnl
activ
enhanc
antibodi
inhibit
presenc
jordan
et
al
suggest
possibl
competit
interact
contrast
signal
enhanc
signal
antivir
effect
ifnl
ndez
et
al
although
ifnar
express
broadli
mani
cell
type
tissu
express
preferenti
epitheli
cell
sommereyn
et
al
consist
pattern
antivir
effect
ifnl
evid
pathogen
target
epitheli
tissu
despit
engag
differ
heterodimer
receptor
postreceptor
signal
event
ifnab
ifnl
bind
exhibit
remark
overlap
signal
pathway
review
detail
elsewher
donnelli
kotenko
durbin
et
al
hoffmann
et
al
kotenko
includ
activ
jakfamili
kinas
phosphoryl
associ
activ
stat
complex
form
transloc
nucleu
induc
express
hundr
isg
similar
ifnab
signal
ifnl
signal
induc
phosphoryl
dumouti
et
al
oisnewton
et
al
et
al
addit
phosphoryl
induc
specif
ifnl
odendal
et
al
odendal
kagan
suggest
distinct
upstream
signal
event
might
differenti
ifnl
activ
ifnab
activ
addit
activ
ifnar
ifnlr
ligand
engag
activ
stat
famili
member
statindepend
signal
cascad
mapk
erk
cohen
princ
koch
finotto
transcript
respons
induc
ifnl
ifnab
similar
bolen
et
al
doyl
et
al
kohli
et
al
lazear
et
al
marcello
et
al
shindo
et
al
zhou
et
al
transcript
signatur
uniqu
ifnl
identifi
gene
induc
ifnl
typic
repres
subset
total
induc
ifnab
ifnl
transcript
respons
gener
lower
magnitud
ifnab
might
exhibit
delay
peak
longer
durat
marcello
et
al
although
differ
express
level
ifnar
ifnlr
might
confound
comparison
differenti
effect
neg
regul
might
contribut
sustain
signal
pattern
observ
ifnl
comparison
ifna
exampl
isg
desensit
cell
ifna
stimul
inhibit
ifnl
signal
oisnewton
et
al
among
ifnl
subtyp
follow
potent
bioactiv
bolen
et
al
dellgren
et
al
differ
potenc
unexpect
given
nearli
ident
amino
acid
ident
sheppard
et
al
ifnab
ifnl
signal
amplifi
ifn
product
exampl
via
induct
transcript
factor
bolen
et
al
kohli
et
al
lazear
et
al
share
positivefeedback
system
transcript
profil
cell
lack
ifnar
ifnlr
presenc
proteinsynthesi
inhibitor
might
need
distinguish
bona
fide
ifnaband
ifnlinduc
gene
independ
whether
truli
ifnlspecif
transcript
signatur
abil
induc
narrow
set
isg
target
set
cell
suggest
possibl
therapeut
applic
ifnl
could
promot
focus
antivir
immunomodulatori
respons
fewer
side
effect
ifnab
muir
et
al
given
ifnl
transcript
profil
experi
focus
human
liver
cell
studi
need
tissu
antivir
effect
ifnl
report
antivir
effect
ifnl
ifnl
exhibit
antivir
activ
mani
virus
vitro
vivo
activ
appar
virus
infect
epitheli
cell
respiratori
gastrointestin
urogenit
tract
well
liver
tabl
antivir
effect
ifnl
review
recent
egli
et
al
obrien
et
al
sorgeloo
et
al
briefli
describ
role
ifnl
respiratori
tract
liver
highlight
new
phenotyp
gastrointestin
tract
well
unexpect
site
bbb
ifnl
respiratori
tract
ifnlr
express
rel
high
level
respiratori
epitheli
cell
mice
treat
ifnl
prior
infect
human
metapneumoviru
hmpv
develop
lower
viral
titer
reduc
inflammatori
respons
oslara
et
al
accordingli
mice
exhibit
increas
suscept
respiratori
viral
infect
includ
influenza
viru
hmpv
respiratori
syncyti
viru
sar
coronaviru
crotta
et
al
contoli
et
al
correspondingli
product
ifnl
correl
invers
viral
load
diseas
sever
human
experiment
inocul
rhinoviru
contoli
et
al
respiratori
epitheli
cell
respond
ifnl
ifnab
cultur
cell
respond
ifnl
apic
basolater
surfac
fox
et
al
ham
et
al
respiratori
syncyti
viru
increas
titer
mice
mordstein
et
al
herp
simplex
viru
treatment
recombin
ifnl
decreas
viral
titer
shed
ank
et
al
lymphocyt
choriomening
viru
chang
viral
titer
mice
increas
cell
respons
acut
infect
decreas
cell
respons
chronic
infect
mice
ank
et
al
misumi
whitmir
human
patient
hepat
c
viru
snp
correl
spontan
clearanc
sustain
respons
ifn
therapi
bibert
et
al
ge
et
al
griffith
et
al
ham
et
al
prokuninaolsson
et
al
suppiah
et
al
tanaka
et
al
thoma
et
al
hepat
b
viru
snp
correl
respons
ifn
therapi
galmozzi
et
al
human
cytomegaloviru
snp
correl
hcmv
retin
aid
patient
snp
correl
hcmv
reactiv
transplant
recipi
bibert
et
al
egli
et
al
egli
et
al
griffith
et
al
manuel
et
al
herp
simplex
viru
snp
correl
sever
reactiv
diseas
griffith
et
al
influenza
viru
increas
viral
titer
epitheli
cell
inhibit
snp
correl
vaccin
respons
immunosuppress
patient
egli
et
al
kim
et
al
rhinoviru
increas
product
ifnl
correl
reduc
viral
replic
bronchial
epitheli
cell
contoli
et
al
jewel
et
al
okabayashi
et
al
impli
key
role
ifnl
mediat
antivir
immun
respiratori
tract
figur
great
interest
defin
antivir
role
ifnl
liver
particularli
hcv
hbv
infect
ifnlr
express
human
hepatocyt
primari
cellular
target
virus
figur
virus
preferenti
stimul
ifnl
product
rather
ifnab
product
marukian
et
al
park
et
al
sato
et
al
thoma
et
al
gwass
reveal
ifnl
polymorph
associ
improv
outcom
hcv
hbv
infect
term
spontan
clearanc
respons
antivir
therapi
galmozzi
et
al
ge
et
al
griffith
et
al
lampertico
et
al
obrien
et
al
russel
et
al
suppiah
et
al
tanaka
et
al
thoma
et
al
differ
protect
allel
identifi
studi
impli
distinct
antivir
mechan
hcv
one
protect
allel
promot
region
associ
increas
ifnl
product
might
control
infect
enhanc
express
isg
snp
protect
allel
tt
rather
tg
gg
suppiah
et
al
tanaka
et
al
howev
unfavor
allel
also
associ
elev
isg
express
thought
render
cell
refractori
stimul
antivir
activ
snp
protect
allel
cc
rather
tc
tt
sheahan
et
al
thoma
et
al
urban
et
al
addit
associ
viral
hepat
predict
sever
liver
inflamm
fibrosi
etiolog
opposit
associ
cc
unfavor
allel
eslam
et
al
dispar
suggest
isg
express
might
differenti
affect
viral
nonvir
liver
diseas
anoth
protect
allel
alter
sequenc
utr
transcript
longer
target
degrad
microrna
induc
hcv
infect
snp
protect
allel
gg
rather
tt
mcfarland
et
al
snp
highli
associ
improv
hcv
outcom
one
protect
allel
frameshift
insert
ablat
product
snp
protect
allel
tt
rather
g
bibert
et
al
ham
et
al
key
et
al
obrien
et
al
prokuninaolsson
et
al
remain
unclear
loss
confer
improv
clinic
outcom
sever
explan
propos
counterregulatori
role
ifn
refractori
state
induc
high
basal
express
stimul
regulatori
cell
respons
andor
reduc
product
antivir
mani
polymorph
within
ifnl
locu
exist
high
linkag
disequilibrium
often
segreg
haplotyp
made
difficult
pars
protect
function
individu
snp
exampl
mani
protect
phenotyp
initi
attribut
cc
allel
might
fact
caus
loss
product
result
highli
link
recent
identifi
tt
allel
signific
interest
therapeut
potenti
ifnl
viral
hepat
donnelli
et
al
hay
et
al
least
introduct
directact
antivir
agent
treat
hcv
infect
alexopoul
karayianni
convent
pegyl
ifna
therapi
accompani
side
effect
hinder
complianc
given
restrict
express
pattern
ifnlr
rel
high
amount
ifnlr
express
hepatocyt
ifnl
could
confer
mani
antivir
benefit
ifna
liver
reduc
side
effect
muir
et
al
although
directact
antivir
agent
supplant
ifn
therapi
hcv
infect
therapeut
advantag
ifnl
might
still
util
hbv
viral
infect
hepat
condit
although
human
hepatocyt
respond
ifnl
mous
hepatocyt
less
respons
instead
cholangiocyt
line
bile
duct
reportedli
princip
cell
respond
ifnl
mous
liver
iv
et
al
observ
could
explain
appar
lack
antivir
activ
ifnl
mous
model
hepatotrop
viru
infect
despit
clear
role
human
hepat
mordstein
et
al
ifnl
respons
cholangiocyt
could
restrict
excret
hepatotrop
virus
bile
thu
control
viral
spread
fece
gastrointestin
tract
primari
site
microbi
exposur
intestin
epitheli
cell
form
barrier
pathogen
virus
bacteria
figur
initi
character
tissu
express
mice
demonstr
rel
high
express
stomach
intestin
sommereyn
et
al
subsequ
studi
reveal
epitheli
cell
predomin
ifnlrespons
cell
type
gastrointestin
tract
mordstein
et
al
pott
et
al
ifnl
ifnab
respons
compartment
within
mous
intestin
ifnab
minim
effect
intestin
epitheli
cell
wherea
ifnl
minim
effect
cell
lamina
propria
pott
et
al
differenti
respons
might
explain
rel
high
express
ifnlr
intestin
epitheli
cell
well
low
express
apic
traffick
ifnar
cell
pott
et
al
although
transcript
express
human
gastrointestin
tract
sheppard
et
al
remain
determin
whether
ifnl
ifnab
respons
similarli
compartment
compartment
respons
ifnl
mous
gastrointestin
tract
like
explain
activ
differ
viral
pathogen
depend
cellular
tropism
rotaviru
infect
epitheli
cell
lopez
aria
reoviru
replic
epitheli
nonepitheli
cell
forrest
dermodi
noroviru
grow
preferenti
myeloid
b
cell
epitheli
cell
jone
et
al
karst
et
al
wobu
et
al
rotaviru
infect
control
exclus
ifnl
defin
role
ifnab
angel
et
al
pott
et
al
reoviru
control
cooper
ifnab
ifnl
ifnl
limit
replic
epitheli
cell
ifnab
restrict
infect
nonepitheli
cell
noroviru
infect
dissemin
control
ifnab
ifnl
ifnab
prevent
extraintestin
spread
ifnl
inhibit
persist
shed
viru
fece
nice
et
al
role
ifnl
noroviru
infect
appar
strain
persist
shed
across
intestin
epitheli
barrier
gut
lumen
strain
caus
acut
fenestr
endothelium
liver
creat
tissu
architectur
hepatocyt
directli
contact
blood
liver
sinusoid
hepatocyt
primari
cellular
target
hbv
hcv
highli
respons
ifnl
role
ifnl
control
hcv
infect
suggest
associ
hcv
clinic
outcom
numer
snp
within
ifnl
locu
c
ifnl
key
role
gastrointestin
tract
immun
unlik
respiratori
epitheli
cell
gut
epitheli
cell
respond
ifnab
therefor
reli
upon
ifnl
activ
antivir
respons
antivir
effect
ifnl
could
especi
import
restrict
shed
transmiss
enter
virus
immun
gastrointestin
tract
shape
bacteri
microbiom
abil
gut
microb
promot
viral
persist
requir
ifnl
signal
although
mechan
interact
remain
unclear
ifnl
signal
tighten
endotheli
junction
bbb
reduc
viral
neuroinvas
circul
tighten
activ
ifnl
independ
implic
noncanon
signal
pathway
e
psoriasi
atop
dermat
chronic
inflammatori
skin
condit
character
breakdown
epitheli
barrier
compar
lesion
atop
dermat
patient
psoriasi
lesion
exhibit
elev
ifnl
product
enhanc
express
isg
might
explain
dissemin
viral
skin
infect
common
patient
atop
dermat
psoriasi
immun
juli
elsevi
inc
review
infect
studi
genet
phenotyp
unrel
gastrointestin
virus
reveal
uniqu
antivir
role
ifnab
ifnl
particular
ifnl
select
prevent
viral
shed
lumen
gastrointestin
tract
transmiss
fecalor
viral
pathogen
trillion
bacteria
juxtapos
intestin
epitheli
barrier
sourc
numer
microbi
product
sens
immun
system
thu
ifnmedi
antivir
respons
gastrointestin
tract
modul
bacteri
microbiom
inde
recent
studi
show
bacteri
microbiom
promot
persist
noroviru
infect
ifnlrdepend
manner
fecal
shed
noroviru
viral
entri
peyer
patch
extraintestin
spread
reduc
mice
treat
antibiot
deplet
bacteri
microbiom
effect
antibiot
noroviru
shed
diminish
mice
trif
mice
lack
innat
immun
signal
compon
specif
requir
ifnlr
bacteri
promot
noroviru
infect
contrast
polioviru
mous
mammari
tumor
viru
mmtv
infect
bacteri
promot
viral
infect
depend
bacteri
lipopolysaccharid
respect
kane
et
al
kuss
et
al
howev
addit
role
ifnl
polioviru
mmtv
infect
remain
possibl
signal
bacteri
infect
induc
ifnl
biern
et
al
coccia
et
al
contoli
et
al
odendal
et
al
experi
requir
character
intestin
product
respons
ifnl
presenc
absenc
enter
bacteria
given
import
ifnl
intestin
immun
mice
studi
test
linkag
human
ifnl
snp
control
enter
viral
infect
appear
warrant
studi
mice
also
suggest
ifnl
might
therapeut
applic
human
persist
noroviru
infect
gastroenter
bok
green
abil
ifnl
confer
antivir
protect
epitheli
barrier
interest
parallel
anoth
famili
cytokin
promot
antibacteri
immun
epitheli
surfac
zheng
et
al
similar
associ
express
preferenti
epitheli
cell
wolk
et
al
recent
studi
demonstr
act
synergist
ifnl
control
rotaviru
infect
prevent
intestin
tissu
damag
mice
ndez
et
al
work
need
determin
whether
contribut
antivir
activ
ifnl
epitheli
surfac
virus
target
gastrointestin
tract
surprisingli
ifnl
stimul
clearanc
persist
noroviru
infect
independ
adapt
immun
system
suggest
innat
immun
respons
might
greater
role
determin
viral
persist
previous
appreci
ifnlr
express
epitheli
cell
ifnl
could
particularli
import
restrict
shed
chronic
viral
infect
consist
idea
ifnl
treatment
decreas
shed
vagin
mucosa
mice
ank
et
al
human
snp
associ
abil
clear
control
multipl
chronic
infect
includ
hcv
hbv
hcmv
bibert
et
al
egli
et
al
egli
et
al
griffith
et
al
griffith
et
al
lampertico
et
al
manuel
et
al
although
mechan
polymorph
affect
ifnl
product
activ
remain
unclear
associ
suggest
ifnl
contribut
control
chronic
viral
infect
human
restrict
ifnlr
express
within
mucos
epithelium
key
cell
type
might
allow
target
local
antivir
respons
control
chronic
infect
shed
without
gener
potenti
deleteri
system
proinflammatori
respons
greater
mechanist
understand
human
snp
influenc
ifnl
express
function
studi
ifnl
addit
model
chronic
viral
shed
need
ifnl
bbb
recent
studi
west
nile
viru
wnv
demonstr
antivir
effect
ifnl
unexpect
barrier
site
bbb
bbb
protect
cn
harm
substanc
peripheri
includ
virus
koyuncu
et
al
mice
exhibit
increas
bbb
permeabl
wnv
infect
sustain
higher
viral
titer
cn
tissu
although
endotheli
cell
includ
compos
bbb
express
high
level
ifnlr
administr
exogen
ifnl
tighten
bbb
restrict
viral
neuroinvas
reduc
viral
titer
cn
protect
mice
lethal
viral
infect
figur
observ
consist
studi
demonstr
ifnab
also
exert
tighten
effect
bbb
daniel
et
al
ifnl
tighten
endotheli
monolay
vitro
model
bbb
requir
de
novo
protein
synthesi
impli
phenotyp
occur
via
noncanon
signal
pathway
although
experi
need
determin
specif
pathway
exert
effect
bbb
integr
studi
suggest
ifnl
might
therapeut
activ
patholog
condit
viral
infect
involv
bbb
breakdown
permeabl
direct
consequ
ifnl
signal
induct
isg
act
cellintrins
manner
inhibit
viral
infect
figur
howev
ifnl
immunolog
role
beyond
innat
antivir
respons
increas
evid
ifnl
shape
adapt
immun
respons
viral
infect
alter
antitumor
respons
affect
autoimmun
alter
express
activ
compon
pathogen
sens
ifninduct
pathway
associ
autoimmun
exampl
alter
prr
signal
molecul
sting
transcript
factor
caus
sever
clinic
syndrom
known
type
interferonopathi
crow
rigbi
rehwinkel
overlap
stimuli
sensor
signal
mechan
induc
express
type
iii
ifn
alter
might
enhanc
ifnl
product
contribut
clinic
phenotyp
given
exert
tighten
effect
bbb
ifnl
could
promin
barrier
effect
epitheli
tissu
ifnlr
express
higher
skin
ifnlr
express
predominantli
keratinocyt
witt
et
al
barrier
function
keratinocyt
import
evidenc
patholog
psoriasi
atop
dermat
two
chronic
condit
character
epitheli
cell
hyperprolifer
impair
barrier
function
inflamm
figur
clark
leung
perera
et
al
patient
atop
dermat
commonli
develop
dissemin
bacteri
eg
staphylococcu
aureu
viral
eg
hsv
human
papillomaviru
molluscum
contagiosum
poxviru
infect
skin
christoph
hensel
wollenberg
et
al
howev
dissemin
infect
characterist
psoriasi
skin
lesion
psoriasi
patient
exhibit
higher
amount
enhanc
express
isg
atop
dermat
lesion
occur
absenc
differenti
express
ifnab
wolk
et
al
although
alter
epitheli
barrier
function
featur
psoriasi
atop
dermat
elev
ifnl
product
isg
express
provid
antivir
protect
context
psoriasi
factor
caus
elev
ifnl
product
psoriasi
understood
might
result
respons
psoriat
lesion
rather
respons
atop
dermat
cell
main
sourc
ifnl
psoriasi
lesion
ifnl
inhibit
product
cytokin
particularli
sriniva
et
al
wolk
et
al
protect
role
ifnl
psoriasi
also
suggest
linkag
snp
utr
diseas
outcom
snp
protect
allel
g
rather
although
mechanist
basi
associ
remain
uncertain
li
et
al
strang
et
al
protect
role
ifnl
allerg
asthma
also
propos
figur
koch
finotto
cell
asthma
patient
impair
ifnl
product
rhinoviru
infect
contoli
et
al
ifnl
downregul
inflammatori
cytokin
includ
jordan
et
al
koltsida
et
al
sriniva
et
al
contribut
asthma
pathogenesi
mous
model
asthma
administr
ifnl
reduc
product
diminish
eosinophil
infiltr
lung
decreas
cell
respons
minim
diseas
koltsida
et
al
protect
activ
ifnl
model
depend
ifng
implic
effect
ifnl
recent
studi
use
mous
model
autoimmun
arthriti
ifnl
treatment
reduc
neutrophil
recruit
joint
result
improv
diseas
outcom
blazek
et
al
work
identifi
neutrophil
ifnlrespons
cell
suggest
therapeut
applic
ifnl
treat
autoimmun
arthriti
inflammatori
condit
despit
linkag
autoimmun
condit
human
snp
near
gene
encod
ifnl
show
associ
multipl
sclerosi
lopez
de
lapuent
et
al
malhotra
et
al
furthermor
allel
protect
psoriasi
associ
exacerb
system
lupu
erythematosu
snp
protect
allel
rather
g
li
et
al
suggest
distinct
contribut
ifnl
signal
differ
autoimmun
condit
ifnl
cancer
ifna
current
approv
therapeut
agent
cancer
primari
antitumor
mechan
ifnab
cellintrins
induct
apoptosi
cellextrins
stimul
prime
immun
cell
booy
et
al
di
trolio
et
al
given
ifnl
signal
trigger
similar
downstream
gene
express
restrict
subset
ifnlrbear
cell
could
serv
target
therapeut
option
support
concept
ifnlr
signal
induc
apoptosi
colorect
cancer
cell
potent
ifnab
ifng
li
et
al
inhibit
growth
coloni
format
sever
differ
tumor
cell
line
sato
et
al
induct
ifnl
respons
viral
infect
could
also
promot
antitumor
immun
respons
ifnl
detect
human
papillomaviru
lesion
lower
level
ifnl
express
correl
progress
cervic
cancer
cannella
et
al
infect
vesicular
stomat
viru
strain
intend
use
oncolyt
treatment
also
trigger
ifnl
express
hematopoiet
cell
vitro
enhanc
antitumor
natur
killer
nk
cell
respons
vivo
wongthida
et
al
loss
ifnlr
express
tumor
cell
prevent
ifnlstimul
express
stimulatori
ligand
nk
cell
receptor
associ
antitumor
nk
cell
respons
wongthida
et
al
ifnl
also
present
tumor
microenviron
absenc
viral
infect
ifnlr
express
mammari
epitheli
cell
invers
correl
tumor
growth
mous
model
breast
cancer
burkart
et
al
ifnl
signal
mammari
epitheli
cell
promot
product
chemokin
recruit
cell
tumor
microenviron
burkart
et
al
tumor
model
melanoma
colon
carcinoma
fibrosarcoma
cell
also
demonstr
role
ifnl
trigger
antitumor
nk
cell
lasfar
et
al
numasaki
et
al
sato
et
al
increas
antitumor
immun
respons
appar
even
tumor
cell
lack
abil
respond
ifnl
lasfar
et
al
numasaki
et
al
recent
work
demonstr
mice
suscept
sarcoma
format
induc
carcinogen
methylcholanthren
death
transplant
tumor
model
either
rma
cell
souzafonsecaguimara
et
al
furthermor
ifnl
treatment
delay
lethal
adopt
cell
transfer
model
reduc
sarcoma
develop
methylcholanthrenetr
mice
souzafonsecaguimara
et
al
despit
low
level
ifnlr
express
nk
cell
might
respond
directli
ifnl
vivo
result
enhanc
ifng
product
antitumor
activ
souzafonsecaguimara
et
al
ifnl
alter
tumorigenesi
directli
indirectli
might
util
adjunct
anticanc
therapi
although
innat
antivir
effect
character
extens
ifnl
also
modul
adapt
immun
acut
lcmv
infect
armstrong
strain
mice
increas
expans
cell
enhanc
cell
respons
lcmv
rechalleng
misumi
whitmir
data
suggest
ifnl
contrast
ifnab
inhibit
cell
respons
acut
viral
infect
effect
cell
extrins
given
ifnlr
signal
requir
cell
misumi
whitmir
howev
ifnl
differ
effect
chronic
lcmv
infect
mice
infect
lcmv
clone
reduc
cell
expans
increas
weight
loss
misumi
whitmir
comparison
mice
show
defect
magnitud
qualiti
antigenspecif
cell
respons
spleen
brain
wnv
infect
indic
virusspecif
host
interact
might
affect
ifnl
modul
adapt
immun
respons
addit
studi
requir
defin
role
ifnl
adapt
immun
mucos
infect
ifnlr
abundantli
express
although
conflict
report
whether
human
lymphocyt
respond
directli
ifnl
dickensheet
et
al
gallagh
et
al
consensu
ifnl
modul
cell
respons
addit
ifnl
stimul
peripheralblood
mononuclear
cell
pbmc
concanavalin
mix
lymphocyt
reaction
reduc
product
cytokin
increas
product
ifng
suggest
ifnl
promot
respons
dai
et
al
jordan
et
al
sriniva
et
al
consist
data
snp
tt
allel
locu
link
increas
product
skew
toward
respons
pbmc
stimul
influenza
viru
egli
et
al
furthermor
administr
ifnl
vaccin
adjuv
result
reduc
express
cytokin
hiv
gagspecif
cell
reduc
number
activ
regulatori
cell
morrow
et
al
collect
observ
suggest
ifnl
skew
cell
respons
toward
cell
bia
away
cell
bia
humor
immun
respons
might
regul
ifnl
although
net
effect
clear
increas
seroconvers
respons
influenza
measl
vaccin
correl
snp
promot
tt
allel
gg
allel
egli
et
al
haralambieva
et
al
tt
allel
snp
link
increas
product
ifnl
decreas
seroconvers
influenza
vaccin
egli
et
al
vitro
experi
show
reduc
antibodi
product
pbmc
stimul
influenza
viru
presenc
ifnl
increas
antibodi
titer
presenc
ifnlrblock
peptid
egli
et
al
contrast
stimulatori
effect
humor
respons
observ
hiv
vaccin
studi
compar
ifnl
adjuv
ifnladjuv
vaccin
result
greater
increas
respons
vaccin
morrow
et
al
howev
context
wnv
lcmv
infect
antivir
antibodi
product
mice
wildtyp
anim
misumi
whitmir
thu
impact
ifnl
humor
immun
appear
context
depend
requir
evalu
although
known
antivir
effect
ifnab
ifnl
might
function
microbi
infect
well
wherea
ifnab
signal
protect
viral
infect
detriment
context
infect
bacteria
eg
mycobacterium
tuberculosi
listeria
monocytogen
parasit
eg
leishmania
spp
stifter
feng
ifnl
also
induc
bacteri
infect
biern
et
et
al
might
consequ
staphylococcu
pseudomona
infect
mice
sustain
lower
bacteri
load
exhibit
less
patholog
without
differ
inflammatori
cell
infiltr
cohen
princ
investig
role
ifnl
nonvir
infect
warrant
effect
ifnl
context
helminth
infect
could
especi
interest
given
abil
downregul
respons
jordan
et
al
sriniva
et
al
given
antivir
effect
ifnl
anticip
virus
evolv
specif
evas
strategi
ifnab
antagonist
mechan
describ
mani
viru
famili
hoffmann
et
al
target
induct
signal
pathway
share
ifnl
ifnab
evas
strategi
like
limit
effect
ifnl
well
virus
target
epitheli
tissu
might
especi
like
encod
specif
ifnlevas
mechan
yabalik
diseas
viru
yldv
primat
poxviru
exclus
infect
skin
similar
orthopoxvirus
yldv
encod
secret
glycoprotein
bind
ifnab
block
ifnar
signal
unlik
ortholog
vaccinia
variola
virus
also
bind
inhibit
antivir
effect
ifnl
bandi
et
al
huang
et
al
structur
ifnl
distinct
ifnab
remain
uncertain
singl
viral
evas
protein
target
ifnl
ifnab
infect
epitheli
cell
larg
genom
enabl
encod
suit
immun
evas
molecul
epperson
et
al
poxvirus
herpesvirus
might
evolv
analog
uniqu
mechan
antagon
ifnl
respons
use
mice
provid
insight
role
ifnl
antivir
immun
ndez
et
al
lazear
et
al
iv
et
al
mordstein
et
al
nice
et
al
nonetheless
differ
ifnl
mice
human
consid
one
interpret
array
activ
wherea
human
three
four
function
ifnl
gene
mice
two
genom
region
absent
mice
mous
pseudogen
compar
human
studi
mous
studi
might
underestim
contribut
ifnl
lack
given
ifnl
transcript
profil
date
focus
human
cell
studi
need
character
ifnl
respons
mous
cell
inform
interpret
mous
model
diseas
ifnl
famili
conserv
throughout
tetrapod
evolut
evidenc
synteni
structur
similar
among
mammalian
avian
amphibian
ifnlencod
gene
comparison
fish
gene
encod
ifnab
ifnl
qi
et
al
antivir
effect
avian
ifnl
document
reuter
et
al
tadpol
ifnl
rather
ifnab
dominantli
inhibit
infect
frog
viru
grayfer
et
al
contrast
preferenti
epitheli
express
pattern
ifnlr
human
mice
bat
pteropu
alecto
ifnlr
express
broader
rang
cell
tissu
zhou
et
al
infect
p
alecto
splenocyt
paramyxoviru
tioman
viru
induc
express
ifnab
zhou
et
al
interest
determin
whether
broader
tissu
respons
ifnl
bat
contribut
abil
serv
reservoir
host
divers
virus
baker
et
al
exampl
enhanc
ifnl
respons
might
enabl
bat
control
viral
infect
without
develop
diseas
altern
sustain
ifnl
signal
might
imped
activ
potent
antivir
respons
prevent
bat
clear
viral
infect
although
mous
rat
genom
lack
gene
conserv
mammal
display
evid
posit
select
impli
function
signific
key
et
al
human
popul
howev
undergo
pseudogen
acquisit
frameshift
insert
open
read
frame
ablat
product
ham
et
al
prokuninaolsson
et
al
frequenc
polymorph
vari
ancestr
allel
domin
african
popul
pseudogen
allel
reach
near
fixat
east
asian
popul
key
et
al
select
pressur
drive
pseudogen
human
remain
unknown
gwass
suggest
strong
associ
pseudogen
allel
improv
outcom
hcv
infect
griffith
et
al
ham
et
al
prokuninaolsson
et
al
hcv
infect
unlik
provid
suffici
select
pressur
drive
evolutionari
process
loss
product
might
advantag
context
infect
inflammatori
condit
sinc
discoveri
mani
group
identifi
contribut
ifnl
antivir
immun
respons
studi
prompt
grow
appreci
uniqu
featur
distinguish
ifnl
ifnab
featur
provid
possibl
target
therapeut
intervent
abil
ifnl
provid
antivir
protect
specif
tissu
site
eg
epitheli
surfac
could
explain
mainten
system
appear
somewhat
redund
ifnab
respons
epitheli
surfac
could
requir
greater
innat
immun
protect
constant
exposur
commens
pathogen
microb
constant
microbi
stimul
epitheli
barrier
could
requir
local
control
without
broadli
activ
system
immun
respons
thu
ifnl
signal
could
control
frequent
persist
lowlevel
infect
epitheli
barrier
potent
inflammatori
system
ifnab
respons
could
reserv
sever
infect
compartment
tissu
respons
ifnl
could
util
therapeut
mean
achiev
antivir
benefit
minim
system
side
effect
associ
inflamm
